Dr. Brent Acker, MD

NPI: 1407147028
Total Payments
$10,253
2024 Payments
$1,719
Companies
46
Transactions
548
Medicare Patients
2,352
Medicare Billing
$257,468

Payment Breakdown by Category

Food & Beverage$10,253 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,253 548 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,937 177 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,590 89 $0 (2024)
Janssen Biotech, Inc. $811.76 51 $0 (2024)
Gilead Sciences, Inc. $790.73 25 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $609.48 34 $0 (2024)
Merck Sharp & Dohme LLC $332.41 20 $0 (2024)
Ironwood Pharmaceuticals, Inc $221.23 13 $0 (2022)
Daiichi Sankyo Inc. $201.35 6 $0 (2020)
GENZYME CORPORATION $190.20 6 $0 (2024)
Allergan, Inc. $178.51 12 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,719 89 ABBVIE INC. ($568.63)
2023 $1,940 99 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($530.61)
2022 $1,587 89 ABBVIE INC. ($704.02)
2021 $1,140 66 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($345.36)
2020 $550.00 33 AbbVie Inc. ($138.99)
2019 $920.60 58 AbbVie, Inc. ($201.65)
2018 $1,194 68 AbbVie, Inc. ($310.32)
2017 $1,202 46 AbbVie, Inc. ($307.17)

All Payment Transactions

548 individual payment records from CMS Open Payments — Page 1 of 22

Date Company Product Nature Form Amount Type
12/20/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $21.90 General
Category: INFLAMMATION AND IMMUNOLOGY
12/17/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.34 General
Category: Gastroenterology
12/16/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $15.70 General
Category: LIVER DISEASE
12/12/2024 Alnylam Pharmaceuticals Inc. GIVLAARI (Drug) Food and Beverage In-kind items and services $17.45 General
Category: Genetic Disease
12/11/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.21 General
Category: Immunology
12/09/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.89 General
Category: IMMUNOLOGY
12/06/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $18.24 General
Category: ENDOCRINOLOGY
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $17.90 General
Category: Gastroenterology
11/25/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $20.68 General
Category: LIVER DISEASE
11/21/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $34.89 General
Category: Immunology
11/20/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $16.23 General
Category: Immunology
11/18/2024 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $24.30 General
Category: INFECTIOUS DISEASE
11/14/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $14.43 General
Category: Immunology
11/13/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $5.21 General
Category: VIROLOGY
11/12/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $4.33 General
Category: VIROLOGY
11/07/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.11 General
Category: IMMUNOLOGY
11/04/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $17.53 General
Category: Immunology
10/31/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $19.37 General
Category: LIVER DISEASE
10/29/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $19.55 General
Category: IMMUNOLOGY
10/17/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $6.60 General
Category: VIROLOGY
10/17/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $4.67 General
Category: VIROLOGY
10/14/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.04 General
Category: IMMUNOLOGY
10/09/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $39.35 General
Category: INFLAMMATION AND IMMUNOLOGY
10/07/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.27 General
Category: Neuroscience
10/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.07 General
Category: Gastroenterology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 537 611 $285,737 $61,544
2022 16 552 638 $293,748 $58,753
2021 12 571 701 $292,756 $64,950
2020 16 692 837 $316,342 $72,221
Total Patients
2,352
Total Services
2,787
Medicare Billing
$257,468
Procedure Codes
59

All Medicare Procedures & Services

59 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 60 60 $56,882 $11,721 20.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 83 108 $42,336 $9,963 23.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 45 77 $15,216 $4,638 30.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 34 34 $27,346 $4,540 16.6%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 49 51 $30,602 $4,514 14.8%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 26 26 $19,422 $4,507 23.2%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 40 40 $14,493 $3,965 27.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 61 65 $17,940 $3,655 20.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 33 33 $16,731 $3,340 20.0%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 15 15 $11,205 $2,605 23.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 18 18 $10,359 $2,377 22.9%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 22 22 $9,741 $1,931 19.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 13 17 $4,617 $1,450 31.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 20 20 $6,780 $1,390 20.5%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 18 25 $2,067 $948.25 45.9%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 48 48 $45,264 $9,366 20.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 74 95 $37,240 $7,607 20.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 58 112 $23,219 $5,995 25.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 62 65 $39,000 $5,505 14.1%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 53 53 $20,913 $5,374 25.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 56 56 $28,392 $4,692 16.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 49 50 $13,800 $3,207 23.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 31 31 $24,583 $2,933 11.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 17 17 $9,232 $2,571 27.8%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 14 15 $11,205 $2,557 22.8%

About Dr. Brent Acker, MD

Dr. Brent Acker, MD is a Internal Medicine healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2011. The National Provider Identifier (NPI) number assigned to this provider is 1407147028.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brent Acker, MD has received a total of $10,253 in payments from pharmaceutical and medical device companies, with $1,719 received in 2024. These payments were reported across 548 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($10,253).

As a Medicare-enrolled provider, Acker has provided services to 2,352 Medicare beneficiaries, totaling 2,787 services with total Medicare billing of $257,468. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Internal Medicine, Gastroenterology
  • Location Savannah, GA
  • Active Since 04/30/2011
  • Last Updated 08/17/2022
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1407147028

Products in Payments

  • XIFAXAN (Drug) $1,091
  • RINVOQ (Biological) $845.64
  • STELARA (Biological) $510.18
  • HUMIRA (Biological) $461.31
  • TRULANCE (Drug) $433.96
  • Humira (Biological) $366.51
  • Entyvio (Biological) $331.92
  • DIFICID (Drug) $318.89
  • MAVYRET (Drug) $305.25
  • REMICADE (Biological) $304.48
  • DUPIXENT (Biological) $301.39
  • LINZESS (Drug) $234.00
  • Viekira (Drug) $220.56
  • Vemlidy (Drug) $220.53
  • Linzess (Drug) $203.28
  • INJECTAFER (Drug) $201.35
  • ENTYVIO (Biological) $173.95
  • SKYRIZI (Biological) $167.84
  • VIBERZI (Drug) $158.90
  • GATTEX (Drug) $149.67

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Savannah